Passive immunity against measles during the first 8 months of life of infants born to vaccinated mothers or to mothers who sustained measles

Vaccine

Volumn 15, Issue 6-7, 1997, Pages 620-623

  De Serres, Gaston ^a   Joly, Jean R ^b   Fauvel, Micheline ^c   Meyer, François ^b   Mâsse, Benoit ^b   Boulianne, Nicole ^a  

^a Ctr de S Pub de Quebec   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

antibody; immunity; infants; measles; vaccine

Indexed keywords

MEASLES ANTIBODY; MEASLES VACCINE; NEUTRALIZING ANTIBODY;

ANTIBODY TITER; ARTICLE; CANADA; CHILD; CONTROLLED STUDY; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MATERNAL DISEASE; MEASLES; MEASLES VACCINATION; NEWBORN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SEROCONVERSION;

ADULT; ANTIBODIES, VIRAL; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFANT; MEASLES; MEASLES VACCINE; MOTHERS; NEUTRALIZATION TESTS;

EID: 0030938149     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00283-6     Document Type: Article

References (15)

1. Black, F.L., Berman, L.L., Borgono, J.M. et al. Geographic variation in infant loss of maternal measles antibody and in prevalence of rubella antibody. Am. J. Epidemiol. 1986, 124, 442-452
2. Krugman, S. Further-attenuated measles vaccine: characteristics and use. Rev. Infect. Dis. 1983, 5, 477-481
3. Lennon, J.L. and Black, F.L. Maternally derived immunity in era of vaccine-protected mothers. J. Pediatr. 1986, 108, 671-676
4. Albrecht, P., Ennis, F.A., Saltzman, E.J. and Krugman, S. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J. Pediatr. 1977, 91, 715-718
5. De Serres, G., Boulianne, N. and Meyer, F. Measles vaccine efficacy during an outbreak in a highly vaccinated population: incremental increase in protection with age at vaccination. Epidemiol. Infect. 1995, 115, 315-323
6. Recommended childhood immunization schedule: United States, January 1995. Morbid. Mortal. Wkly Rep. 1995; 43, 959-960
7. Albrecht, P., Herrmann, K. and Burns, G.R. Role of virus strain in conventional and enhanced measles plaque neutralization test. J. Virol Meth. 1981, 3, 251-260
8. Pabst, H.F., Spady, D.W., Marusyk, R.G. et al. Reduced measles immunity in infants in a well-vaccinated population. Pediatr. Infect. Dis. J. 1992, 11, 525-529
9. Carson, M.M., Spady, D.W., Albrecht, P. et al. Measles vaccination of infants in a well-vaccinated population. Pediatr. Infect. Dis. J. 1995, 14, 17-22
10. Maldonato, Y.A., Lawrence, E.C., DeHovitz, R., Hartzell, H. and Albrecht, P. Early loss of passive measles antibody in infants of mothers with vaccine induced immunity. Pediatrics 1995, 96, 447-450
11. Berzofsky, J.A., Epstein, S.L. and Berkower, I.J. Antigen-antibody interactions and monoclonal antibodies. In Fundamental Immunology, 2nd edn (Ed. Paul, W.E.). Raven Press, New York, 1989
12. Bin, D., Zhihui, C., Qichang, L. et al. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang province. China. Bull. WHO 1991, 69, 415-423
13. Markowitz, L., Albrecht, P., Rhodes, P. et al. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Pediatrics 1996, 97, 53-58
14. Chen, R.T., Markowitz, L.E., Albrecht, P. et al. Measles antibody: reevaluation of protective titers. J. Infect. Dis. 1990, 162, 1036-1042
15. Boulianne, N., De Serres, G., Ratnam, S., Ward, B.J., Joly, J.R. and Duval, B. Measles, mumps, and rubella antibodies 5 to 6 years after immunization: effect of vaccine type and age at vaccination. Vaccine 1995, 13, 1611-1616